Document:

Exhibit

Exhibit 10.2

VICE PRESIDENTS, REGIONAL DIRECTORS, DIRECTORS & OFFICERS
 NON-SOLICITATION, NON-COMPETITION 
AND CONFIDENTIALITY AGREEMENT

This VICE PRESIDENTS, REGIONAL DIRECTORS, DIRECTORS & OFFICERS NON-SOLICIATION, NON-COMPETITION AND CONFIDENTIALITY AGREEMENT (the "Agreement") is entered into as of the 5th day of March 2018, and made effective as of August 1, 2018 (the “Effective Date”), by and between American Renal Associates LLC, a Delaware limited liability company, American Renal Holdings, Inc. (“ARH”), American Renal Management LLC (the “Company”), and their affiliated subsidiaries, parents, and related or joint venture entities (collectively "ARA"), and the employee executing this Agreement ("Employee").
RECITALS

WHEREAS, Employee previously executed a Non-Solicitation, Non-Competition and Confidentiality Agreement with the Company on or about May 9, 2011 (the “2011 Agreement”); and 

WHEREAS, in consideration of the employment and/or continued employment of the Employee and any discretionary bonus, the mutual covenants and agreements contained herein, the sufficiency and adequacy of which Employee hereby recognizes, and any other or further consideration which may be or has been provided to Employee in conjunction with the execution of this Agreement; and 

WHEREAS, execution of this Agreement by Employee is an express condition of Employee's employment and/or continued employment by Employer;

THE PARTIES HEREBY AGREE AS FOLLOWS:

1.1    General.  The Employee acknowledges that in the course of the Employee’s employment with ARA the Employee has become familiar with trade secrets and other confidential information concerning ARA and its subsidiaries, that the Employee’s services were of special, unique and extraordinary value to ARA and its affiliates, and that but for Employee’s employment with ARA, Employee would not have had access to ARA’s trade secrets or other confidential information.

1.2    Non-Solicitation.  In further consideration of Employee’s employment, Employee agrees that for a period of two (2) years following the termination of Employee’s relationship with the Company and the expiration of any paid-time-off (“PTO”) or severance period(s) (the “Nonsolicitation Period”), the Employee shall not (i) solicit any of ARA’s employees to work for any competing dialysis facility/company, (ii) hire any of ARA’s employees to work (as an employee or an independent contractor) for any competing dialysis facility/company, (iii) take any action that may reasonably result in any of ARA’s employees going to work (as an employee or an independent contractor) for any competing dialysis facility/company, (iv) induce any patient or customer of ARA, either individually or collectively, to patronize any competing dialysis facility/company; (v) request or advise any patient, customer, or supplier of ARA to withdraw, curtail, or cancel such person’s business with ARA; (vi) enter into any contract the purpose or result of which would benefit Employee if any patient or customer of ARA were to withdraw, curtail, or cancel such person’s business with ARA; (vii) solicit, induce, or encourage any physician (or former physician) either affiliated with ARA or who becomes known to ARA or Employee through its business development activities or induce or encourage any other person under contract with ARA to curtail or terminated such person’s affiliation or contractual relationship with ARA; (viii) disclose to any Person the names or addresses of any patient or customer of ARA or of any physician (or former physician) affiliated with ARA; or (ix) disparage ARA or any of its agents, employees, or affiliated physicians in any fashion.

1.3     Non-Competition.  During the period of his employment and for a period of two (2) years following the termination of Employee’s relationship with the Company and the expiration of any paid-time-off or severance period(s), irrespective of the reason or absence of reason for such termination (the “Restrictive Period”), the Employee will not, directly or indirectly, compete with the Company and/or its affiliates as an owner, partner, member, shareholder, consultant, agent, employee, director or co-venturer of any business (i) engaged in 

Exhibit 10.2

the kidney dialysis business and/or the operation of kidney dialysis facilities within 10 miles of any such facility owned and operated by ARH or its affiliates and subsidiaries, (ii) engaged in the kidney dialysis business and/or the operation of kidney dialysis facilities where the Employee is involved in a program to establish joint ventures with nephrologists in the United States of America, and (iii) in the case of a termination of employment that occurs on or before the second anniversary of the Effective Date, engaged in the kidney dialysis business and/or the operation of kidney dialysis facilities in the United States of America. In addition to the foregoing, the Employee will not during the Restrictive Period represent any other entity or business enterprise in conducting substantial negotiations with any nephrologists with whom such Executive had conducted substantial negotiations on behalf of ARH or its affiliates and subsidiaries during the one (1) year period immediately prior to the termination of such Employee’s employment with the Company, however such termination may occur, for the purpose of establishing a business relationship between such nephrologists and such other entity or business enterprise. Notwithstanding the foregoing, this Section 1.3 is not intended to prohibit or restrict the Employee from (i) holding a direct or indirect equity interest in ARH, or (ii) owning up to five percent (5%) of the outstanding stock of a publicly held corporation that competes with ARH or its affiliates and subsidiaries.  

1.4    Confidentiality.  “Confidential Information” means (a) all information acquired by Employee from ARA, its employees, its suppliers or customers, its agents or consultants, or others, during Employee’s relationship with ARA, that relates to the present or potential businesses, products or services and operations or processes of ARA, as well as any other information as may be designated by ARA as confidential or that a reasonable person would understand from the circumstances of the disclosure to be confidential.  Employee acknowledges and agrees that: (i) in the course of employment by the Company, it will or may be necessary for Employee to create, use, or have access to information and materials that concern ARA’s business; (ii) all Confidential Information are the property of ARA; (iii) the use, misappropriation, or disclosure of any Confidential Information would constitute a breach of trust and could cause serious and irreparable injury to ARA; and (iv) it is essential to the protection of ARA’s goodwill and maintenance of ARA’s competitive position that all Confidential Information be kept confidential and that Employee not disclose any Confidential Information to others or use Confidential Information to Employee’s own advantage or the advantage of others.

1.5    Compliance and Acknowledgement.  To enable the Company to monitor compliance with the non-competition, non-solicitation, and confidentiality obligations imposed by this Agreement, Employee further agrees to inform in writing the Company’s Chief Executive Officer, Joseph Carlucci, of the identity of Employee’s subsequent employer(s) and prospective job title(s) and responsibilities prior to beginning employment.  Employee agrees that this notice requirement shall remain in effect for one (1) year following the termination of Employee’s employment at the Company.  Employee acknowledges and agrees that the covenants in Sections 1.2, 1.3, 1.4 have unique, substantial and immeasurable value to the Company, that Employee has sufficient skills to provide a livelihood for Employee while this covenant remains in force, and that these covenant will not interfere with Employee’s ability to work consistent with Employee’s experience, training, and education.

(b) Not Employment Contract. The Employee acknowledges that this Agreement does not constitute a contract of employment and does not guarantee that the Company or any of its subsidiaries will continue his/her employment for any period of time or otherwise change the at-will nature of his/her employment.
            (c) Interpretation. If any restriction set forth in herein is found by any court of competent jurisdiction to be invalid, illegal, or unenforceable, it shall be modified to the minimum extent necessary to render the modified restriction valid, legal and enforceable. The parties intend that the non-competition and non-solicitation provisions contained in this Agreement shall be deemed to be a series of separate covenants, one for each and every county of each and every state of the United States of America and each and every political subdivision of each and every country outside the United States of America where this provision is intended to be effective.

Exhibit 10.2

            (d) Severability. The invalidity or unenforceability of any provision of this Agreement shall not affect the validity or enforceability of any other provision of this Agreement.
            (e) Waiver of Rights. No delay or omission by the Company in exercising any right under this Agreement will operate as a waiver of that or any other right. A waiver or consent given by the Company on any one occasion is effective only in that instance and will not be construed as a bar to or waiver of any right on any other occasion. 
            (f) Equitable Remedies. The restrictions contained in this Agreement are necessary for the protection of the business and goodwill of the Company and its subsidiaries and are considered by the Employee to be reasonable for such purpose. The Employee agrees that any breach of this Agreement is likely to cause the Company substantial and irrevocable damage and therefore, in the event of any such breach, the Employee agrees that the Company, in addition to such other remedies which may be available, shall be entitled to specific performance and other injunctive relief.
             (g) Governing Law. This Agreement shall be governed by and construed in accordance with the laws of the Commonwealth of Massachusetts. Any action, suit, or other legal proceeding which is commenced to resolve any matter arising under or relating to any provision of this Agreement shall be commenced only in a court within the Commonwealth of Massachusetts (or, if appropriate, a federal court located within Massachusetts), and the Company and the Employee each consents to the jurisdiction of such a court.
(h) Entire Agreement.  This Agreement sets forth the entire understanding and agreement between the parties and supersedes any and all oral or written agreements or understandings between the parties as to the subject matter of this Agreement and in particular the 2011 Agreement.
      THE EMPLOYEE ACKNOWLEDGES THAT HE/SHE HAS CAREFULLY READ THIS AGREEMENT AND UNDERSTANDS AND AGREES TO ALL OF THE PROVISIONS IN THIS AGREEMENT.
IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first above written.
EMPLOYEE                       AMERICAN RENAL ASSOCIATES, LLC
/s/ Jason Boucher                    By: /s/ Joseph A. Carlucci                
Print Name: Jason Boucher                Its:  CEOptgx_Ex10_2

		
			Exhibit 10.2
		

		
			 
		

			
					
						 

					
					
						 

					
					
						Protagonist Therapeutics Inc

				
	
					
						 

					
					
						 

					
					
						 

				
	
					
						

					
					
						Protagonist
Therapeutics

					
					
						7707 Gateway Blvd., Ste 140

					
						Newark, CA 94560

					
						 

					
						United States of America

					
						 

					
						Tel +  1 408 649 7370

					
						Fax +  1 649 649 7377

				
	
					
						 

					
					
						 

					
					
						 

				
	
					
						 

					
					
						 

					
					
						www.protagonist-inc.com

				

		
			05/21/2018
		

		
			 
		

		
			Samuel Saks
		

		
			2759 Broderick Street
		

		
			San Francisco, CA 94123
		

		
			(650) 773-3926
		

		
			Dear Sam,
		

		
			 
		

		
			On behalf of Protagonist, a biopharmaceutical company dedicated to discovering and developing peptides as novel pharmaceutical drugs, I am happy to extend to you an offer of part-time employment in our organization as Chief Development Officer reporting directly to Dinesh Patel, President & CEO starting on Monday, May 21, 2018.
		

		
			 
		

		
			Specifically, this letter will confirm in writing the terms of Protagonist's offer to you:
		

		
			 
		

		
			1.    This is a salaried regular position exempt from state and federal wage and hours laws and regulations. Your annual base salary will be $100,000. Your base salary will be paid in accordance with the Company's normal payroll procedures and will be subject to applicable withholding required by law. Presently employees are paid on the 15th and on the last day of each month. You will be eligible for a discretionary annual bonus of up to 40% of your base salary, prorated to actual days of employment in a calendar year based on the accomplishment of corporate and personal goals. You must be employed by the Company on the date on which the bonus is paid. The Company reserves the right to change your position, duties, work location, reporting relationship and compensation from time to time in its discretion.
		

		
			 
		

		
			2.    As a part-time (up to 25%) employee of the Company, promptly following commencement of your employment, which will be Monday, May 21, 2018, and as a material inducement to your employment by the Company, you will be granted by the Compensation Committee of the Board of Directors (the "Committee") an option to purchase 50,000 (fifty thousand) shares of the Company's Common Stock (the "Option") pursuant to the Protagonist Therapeutics, Inc. 2018 Inducement Plan, to be adopted by the Board of Directors in connection with the grant of the Option (the "Plan"). The exercise price per share for the Option shall be equal to the Fair Market Value (as defined in the Plan) as of May 31, 2018 (the effective date of grant based on your employment start date). The Option will be subject to the terms and conditions of the Plan and the applicable grant notice and option agreement. The Option shall vest in 12 equal monthly installments, subject to your continuous service to the Company as of each such vesting date.
		

		
			 
		

		
			
		

		
			

		 

 

		

		
			 
		

		
			3.    As a Protagonist employee, you will be expected to abide by Company rules and policies, and sign and comply with the Proprietary Information and Inventions Agreement, which prohibits unauthorized use or disclosure of Protagonist's proprietary information.
		

		
			 
		

		
			4.    In your work for the Company, you will be expected not to use or disclose any confidential or proprietary information, including trade secrets, of other companies or third parties. If you have or have had access to trade secrets or other confidential, proprietary information from your former employer or another third party, the use of such information in performing your duties at the Company is prohibited. This may include, but is not limited to, confidential or proprietary information in the form of documents, magnetic media, software, customer lists, and business plans or strategies. You will be expected to use only that information which is generally known and used by persons with training and experience comparable to your own, which is common knowledge in the industry or otherwise legally in the public domain, or which is otherwise provided or developed by the Company. During our discussions about your proposed job duties, you assured us that you would be able to perform those duties within the guidelines just described. You must also advise the Company before your employment start date of any restrictions on your ability to work for the Company, such as any covenants not to compete or solicit with any former employers. The Company reserves the right to rescind this offer should it determine that such restriction poses a legal risk to the Company.
		

		
			 
		

		
			5.    You agree that you will not bring onto Company premises any unpublished documents or property belonging to any former employer or other person to whom you have an obligation of confidentiality.
		

		
			 
		

		
			6.    Your employment will be "at will". You may terminate your employment with Protagonist at any time and for any reason whatsoever simply by notifying Protagonist. Likewise, Protagonist may terminate your employment at any time and for any reason whatsoever, with or without cause or advance notice. This at-will employment relationship cannot be changed except in a writing signed by a Company officer.
		

		
			 
		

		
			7.    To ensure the rapid and economical resolution of disputes that may arise in connection with your employment with the Company, you and the Company agree that any and all disputes, claims, or causes of action, in law or equity, including but not limited to statutory claims, arising from or relating to the enforcement, breach, performance, or interpretation of this Agreement, your employment with the Company, or the termination of your employment, shall be resolved, to the fullest extent permitted by law, by final, binding and confidential arbitration in San Francisco, California conducted by JAMS or its successor, under JAMS' rules and procedures for employment disputes (which can be downloaded at http://www.jamsadr.com/rules-employment-arbitration/ or will be provided to you upon request). You acknowledge that by agreeing to this arbitration procedure, both you and the Company waive the right to resolve any such dispute through a trial by jury or judge or administrative proceeding. All claims, disputes or causes of action, by either you or the Company, must be brought in an individual capacity, and shall not be brought as a plaintiff (or claimant) or class member in any purported class or representative proceeding, nor brought in a private attorney general capacity or proceeding, nor joined or consolidated with any claims of any other person or entity. You will have the right to be represented by legal counsel at any arbitration proceeding. The arbitrator shall: (a) have the authority to compel adequate discovery for the resolution of the dispute and to award such relief as would otherwise be permitted by law; and (b) issue a written statement signed by the arbitrator regarding the disposition of each claim and the relief, if any, awarded as to each claim, the reasons for the award, and the arbitrator's essential findings and conclusions on which the award is based. The arbitrator shall be authorized to award all relief that you or the Company would be entitled to seek in a court of law. The Company shall pay all JAMS arbitration fees in excess of the administrative fees that you would be required to pay if the dispute were decided in a court of law. Nothing in this letter agreement is intended to prevent either you or the Company from obtaining injunctive relief in court to prevent irreparable harm pending the conclusion of any such arbitration.
		

		
			 
		

		
			8.    This offer is contingent upon completion of a satisfactory background check. As required by law, this offer is subject to satisfactory proof of your identity and eligibility to work in the United States.
		

		
			 
		

		
			
		

		
			

		 

 

		

		
			 
		

		
			9.    This letter, together with your Proprietary Information Agreement, forms the complete and exclusive statement of your agreement with the Company concerning the subject matter hereof. The terms in this letter supersede any other representations or agreements made to you by any party, whether oral or written. The terms of this agreement cannot be changed (except with respect to those changes expressly reserved to the Company's discretion in this letter) without a written agreement signed by you and a duly authorized officer of the Company. This agreement is to be governed by the laws of the state of California without reference to conflicts of law principles.
		

		
			 
		

		
			At Protagonist, we're creating a great environment for employees to work in synergy with each other, and are excited at the prospects of you joining us in this adventure. We look forward to your significant contributions towards accomplishing our common goals. I would like to emphasize that Protagonist offers exceptional opportunities for achieving valuable industrial experience, personal career growth, and individual recognition. Please do not hesitate to contact me if you have any questions.
		

		
			 
		

		
			To indicate your acceptance of our offer, please sign and date one copy of this letter in the space provided below and return it to us. If you accept our offer, we would like you to start working at the US site no later than May 21, 2018.
		

		
			Sincerely yours,
		

		
			 
		

		
			
		

		
			 
		

		
			Dinesh V. Patel, Ph.D.
		

		
			President & CEO
		

		
			Protagonist Therapeutics
		

		
			I accept your offer of employment as described above:
		

		
			 
		

			
					
						

					
					
						

				
	
					
						Samuel Saks

					
					
						Date

				

		
			 
		

		
			Enclosures: Proprietary Information Agreement

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00286-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00286-of-00352.parquet"}]]